PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
20-Feb-2024 Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary Businesswire
20-Feb-2024 Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities Businesswire
20-Feb-2024 OmniAb to Participate in Two Investor Conferences in March Businesswire
20-Feb-2024 Apollo Intelligence, a Frazier Healthcare Portfolio Company, Acquires GlocalMind, Expanding its Global Reach and Operations in Healthcare and Life Science Market Insights Businesswire
20-Feb-2024 NextPoint Therapeutics Announces First Patient Dosed in Phase 1a/b Clinical Trial of NPX887, a Novel Therapeutic Targeting HHLA2 to Reactivate Exhausted T and NK Cells in HHLA2+ Solid Tumors Businesswire
20-Feb-2024 Global Medical Plastics Strategic Research Report 2024: Market to Surpass $50 Billion by 2030 - Advancements in Medical Plastics and Production Capabilities Drive Innovative Applications - ResearchAndMarkets.com Businesswire
20-Feb-2024 Aston University awarded share of £1.7m for research to aid oral delivery of therapeutics Aston University
20-Feb-2024 Global End-to-End Solutions Partner to Life Sciences Organisations, AscellaHealth, Joins Manchester Science Park Businesswire
20-Feb-2024 New U Hair™ Unveils Revolutionary TrichoBioScan™: Experts Calling It Key to Unlocking One’s Unique Hair Loss Mysteries Newswire
20-Feb-2024 Satellos Announces Upcoming Presentations at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference Businesswire
20-Feb-2024 Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences Businesswire
20-Feb-2024 Marinus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 Businesswire
20-Feb-2024 Saama Announces Industry Veteran Bhaskar Sambasivan as New CEO Businesswire
20-Feb-2024 U.S. Food and Drug Administration (FDA) Accepts Supplemental New Drug Application for KRAZATI® (adagrasib) in Combination with Cetuximab as a Targeted Treatment Option for Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or... Businesswire
20-Feb-2024 FineHeart Widens International IP Protection for FlowMaker® Businesswire
20-Feb-2024 KalVista Pharmaceuticals Awarded UK Innovation Passport for Sebetralstat Businesswire
20-Feb-2024 Quest International Enhances World-Class Logistics Services by Doubling Its Warehousing Capacity Newswire
20-Feb-2024 Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCɣRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT) Newswire
20-Feb-2024 Diakonos Oncology Names Paul Lammers, M.D., Veteran BioPharma Senior Executive, to its Board of Directors Businesswire
20-Feb-2024 Florence Healthcare and Slope Unite Forces to Address Site Technology Ecosystem Demand Newswire